GLP-RT 30mg provides a larger quantity of peptide suitable for extended experimental programs
By week 48 (approximately one year), participants lost more than 24% of their starting weightan average of about 58 pounds.[4] This level of weight loss appears greater than what has been observed in studies of medications like Wegovy or Ozempic.[6,7] Additionally, nearly all 338 participants who took lower doses of retatrutide experienced weight reductions between 5% and 15%.[4] Even modest weight loss can have meaningful health benefits
Immediate support when something feels off If the color, temperature, smell, or appearance concerns you We validate it before you inject
In the 2025 FDA label, the SURPASS-1 monotherapy trial showed statistically significant A1c reductions versus placebo over 40 weeks, with body-weight reductions ranging from 6.3 kg to 7.8 kg depending on dose
This compounded preparation: Has not been approved by the FDA Has not undergone FDA review for safety, effectiveness, or quality Is prepared specifically for you based on your prescriber's order Individual outcomes may vary Disclaimer: Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the U.S
C15:0, the ingredient in fatty15, is GRAS (generally regarded as safe) certified, which means fatty15 is safe for children age 4+, pregnant women, nursing moms, and pretty much everyone except for infants and toddlers